Taiho launches strategic VC arm

Taiho Pharmaceutical Co. Ltd. (Tokyo, Japan) launched Taiho Ventures, a strategic investment arm headquartered in California, with $50 million. The firm intends to invest in cancer start-ups globally, with a focus on the U.S., Europe and Japan.

In 2014, Taiho committed $30 million to newly launched Remiges Ventures' first fund to gain exposure to early stage research. At the time, Taiho Head of Corporate Strategy Nobuyuki Hashimoto told BioCentury that the company would consider additional investments in venture funds (see BioCentury, Aug. 4, 2014). ...